summary Vitamin D deficiency is very common in patients with rheumatoid arthritis (RA). Aim of this study was to evaluate the prevalence of vitamin D deficiency among the different Italian regions and whether these variations are associated with different severity of the disease. The study includes 581 consecutive RA patients (464 women), not taking vitamin D supplements, from 22 Italian rheumatology centres uniformly distributed across Italy. Together with parameters of disease activity (disease activity score 28), functional impairment (activities of daily living and health assessment questionnaire disability index) and mean sun exposure time, all patients had serum 25-hydroxyvitamin D (25OHD) measured in a centralized laboratory. Vitamin D deficiency (25OHD level <20 ng/mL) was very frequent among RA patients; its prevalence was 60%, 52% and 38% in southern, central and northern Italy, respectively. Mean disease activity and disability scores were worse in southern regions of Italy. These scores were inversely related to 25OHD levels and this correlation remained statistically significant after adjusting for both body mass index (BMI) and sun exposure time. However, disease severity remained significantly higher in southern regions versus central-northern Italy after adjustment also for serum 25OHD levels, age and BMI. In RA Italian patients there are significant regional differences in the prevalence of vitamin D deficiency explained by different BMI, and sun exposure time, and inversely associated with disease activity and disability scores.
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n INTRODUCTION V itamin D deficiency is extremely common in Europe and particularly in Southern countries (1, 2) , not only in elder people but also among young subjects (3) . Recently in an Italian multicentric study (4) , involving more than one thousand patients affected by rheumatoid arthritis (RA), we showed that more than half of the patients was vitamin D deficient, defined as serum 25-hydroxyvitamin D (25OHD) concentration <20 ng/mL (5, 6). In the same study (4) we confirmed that the main determinants of serum vitamin D level are also in RA patients body mass index (BMI) and sun exposure time. A significant inverse correlation was found between 25OHD serum level and disease activity or disability scores (4), while bone erosions were associated with higher parathyroid hormone levels (7) . Similar findings in smaller cohort of patients were reported by other authors (8-10), but not all (11) (12) (13) . The causal link between vitamin D deficiency and disease severity could not be ascertained since sun exposure time was also lower in these patients and sun exposure may be dependent on disease severity and then the propensity to stay outside. The aim of this sub-analysis of the Italian multicentric study (4) is to evaluate the regional differences in the prevalence of vitamin D deficiency, and whether these are associated with differences in the activity of the disease. Figure 1 ). The diagnosis of RA was made according to the American College of Rheumatology 1987 criteria (14) . Subjects with comorbilities such as insulin-dependent diabetes or severe renal or hepatic failure were excluded. The study was in compliance with the Helsinki Declaration and was approved by the local Ethical Committees. An informed written consent was obtained from all participants.
n MATERIALS AND METHODS

Patients
Clinical evaluation
All patients were interviewed and examined at each clinical center for the gathering of information on disease and treatment history. Disease-related variables included disease onset and duration, presence of extra-articular manifestations, 28 tender joint count (TJC28) and 28 swollen joint count (SJC28). The three-variable disease activity score (DAS 28) was calculated using C-reactive protein (CRP) and the Nijmegen formula (15): DAS28=(0.56*sqrt(TJC28) + 0.28*sqrt (SJC28) + 0.36*ln(CRP+1)) *1.10 + 1.15. Clinical measures of disease related functional impairment included health assessment questionnaire disability index (HAQ), and the mobility activities of daily living (ADL). RA specific treatment details were collected for glucocorticoids, disease modifying anti-rheumatic drugs: methotrexate, cyclosporine, gold salts, sulfasalazine, antimalarials, and azathioprine, and the tumor necrosis factor-α blockers (anti-TNF). Patients were interviewed regarding current use of drugs affecting bone metabolism including bisphosphonates, calcium and vitamin D supplements. Exposure to sunlight from March to September (sun exposure time) was quantified with a semiquantitative scale from 0 to 3 as follow: <10, 10 to 20, 20 to 30 or >30 min daily (4). Body weight and height (Harpender stadiometer) were assessed and the BMI (kg/m²) was calculated in all subjects.
Laboratory assessment
Rheumatoid factor, anti-cyclic citrullinated peptide and routine biochemistry were 
Statistical analysis
All data management and analysis were centralized and conducted by one of the centres. The differences between subgroups were assessed by t-test or analysis of variance (ANOVA); analysis of covariance (ANCOVA) was used to adjust values for confounding factor. Chi-square tests were used for categorical data. Associations between continuous variables were examined using Pearson correlation coefficients (r) and multivariate linear regression. Differences were considered significant at P<0.05.
All statistical procedures were carried out using a medical statistics computer program (SPSS version 13.0, Inc., Chicago, IL, USA).
n RESULTS
The study patients were divided in three subgroups by regions of residence in the north, the center or the south of Italy. The mean age (56±11 years) and disease duration (132±105 months) were not significant different in the 3 subgroups of patients. Similar were also the seasonal distribution of serum sampling and the RA specific treatment.
Significant differences between north-center and south were observed in BMI (25.0 vs 25.8, respectively, P=0.033) and in degree of sun exposure time score (1.8 vs 1.6, respectively, P=0.02).
The prevalence of vitamin D deficiency (25OHD<20 ng/mL) was more common (P<0.01) in the south and centre than in the north (60.1%, 51.8%, and 37.5%, respectively) (Fig. 2) . The mean 25OHD levels in each macroregion are shown in Figure 3 , according with the season of blood collection: a seasonal trend was apparent but the lower mean 25OHD serum levels in the south were confirmed (P<0.05) also for values adjusted for the month of blood collection. Our findings may be explained at least in part by the significantly higher mean BMI values observed in patients from south Italy, since BMI is known to be inversely associated to serun levels of 25OHD (4). Another explanation is that more hours of sunlight do not mean necessarily longer sun exposure! During summer but also spring, sunlight is so burning that traditionally people living in southern Mediterranean regions avoid sunlight exposure. Indeed, in our patients series sun exposure was significantly shorter in the south as compared to centernorth Italy.
In our study we observed that both disease activity and disability scores were worst in patients living in the southern regions. Of interest are the observed correlations between 25OHD serum levels and disease activity (DAS28) and disability scores (HAQ and ADL) that remained significant after correction for BMI (data not shown).
The explanation of this finding is not clear since we are not in the condition to control for a number of factors such as the selection of the patients included in the study and the average standard of care. However these correlations remained significant also by analyzing only southern patients. Twelve studies evaluated the association between 25OHD levels and RA (4, (8) (9) (10) (11) (12) (13) (19) (20) (21) (22) (23) .
Nine of these studies showed that 25OHD serum levels are inversely associated with RA activity, such as, DAS28. It is conceivable that patients with more severe disease are also likely to spend less hours out-door, and that this may lead to lower 25OHD levels in not supplemented patients, but the 25OHD difference between south and north Italy and the correlation between 25OHD levels and disease activity or functional impairment, remained statistically significant also when the 25OHD levels were adjusted for sun exposure time. This latter observation might be explained by the recent report that 25OHD serum concentration decreases in inflammatory conditions (24) generating a vicious circle where inflammation is responsible of lower 25OHD levels which, in turn, might lead to worsening of the disease as suggested by the multiple effects of vitamin D on immune system (25) and muscle performance (26) . Our findings are far from conclusive in establishing a causal relationship between low 25OHD levels and disease severity in RA patients. We have been unable to control the clinical data for the standard of care and we cannot exclude that patients seen in the secondary care centers of the south of Italy are more selected for their severity. The causality link between low 25OHD levels and disease severity can be determined only with longitudinal intervention studies. Nevertheless the mean DAS 28, HAQ and ADL scores remained significantly higher in the south as compared to northern and central regions also after adjustment for 25OHD serum levels. The poorer control of disease activity in southern Italy is likely to be related to other factors. Recently, a deleterious effects of higher BMI on clinical control of RA (27) and on the response to treatment (28) was reported and, indeed, in our study significantly higher BMI values were observed in southern regions, but in a multivariate analysis the correlation of BMI with clinical scores was not significant. In conclusion in RA Italian patients there are significant regional differences in the prevalence of vitamin D deficiency and these are associated with different disease activity and disability scores. Even though a causal link between vitamin D deficiency and RA severity remains to be established, our results indicate that vitamin D supplementation must be recommended to all patients even if only for the prevention of secondary osteoporosis (29) . 
